SPECIFIC CHROMOSOMAL-ABNORMALITIES IN MALIGNANT HUMAN GLIOMAS
- 15 January 1988
- journal article
- research article
- Vol. 48 (2) , 405-411
Abstract
Karyotypic analysis of 54 malignant human gliomas (5 anaplastic astrocytomas, 43 glioblastoma multiformes, 3 gliosarcomas, 2 giant cell glioblastomas, 1 anaplastic mixed glioma) has demonstrated that 12 tumors contained normal stemlines or only lacked one sex chromosome. The 42 tumors with abnormal karyotypes included 38 tumors which could be completely analyzed. Six of these 38 cases had near-triploid or near-tetraploid stemlines and 32 had near-diploid stemlines. Statistically significant numerical deviations in the near-diploid group were gains of chromosome 7 (26 of 32; P < 0.001), and losses of chromosome 10 (19 of 32; P < 0.001). Double minutes occurred in 18 of 32 near diploid tumors. The distribution of structural abnormalities was analyzed statistically by comparing the incidence of breakpoints in each chromosomal arm to the expected value based on chromosomal arm length. This analysis demonstrated that structural abnormalities of 9p and 19q were significant statistically (P < 0.005 and P = 0.02, respectively). Although chromosome 1, 6p, the centromeric region of chromosome 11, 13q, and 15q were also frequently involved in structural abnormalities, the incidence of these breaks did not reach statistical significance. This demonstration of specific chromosomal abnormalities in near-diploid gliomas provides the basis for the investigation of genes which may be quantitatively or qualitatively altered in these neoplasms.This publication has 24 references indexed in Scilit:
- Chromosome analysis in hematologic disordersThe American Journal of Medicine, 1984
- Cytogenetics of human malignant melanoma and premalignant lesionsCancer Genetics and Cytogenetics, 1984
- Chromosome studies in two human brain tumorsCancer Genetics and Cytogenetics, 1983
- COMPARISONS OF CARMUSTINE, PROCARBAZINE, AND HIGH-DOSE METHYLPREDNISOLONE AS ADDITIONS TO SURGERY AND RADIOTHERAPY FOR THE TREATMENT OF MALIGNANT GLIOMA1983
- Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.Proceedings of the National Academy of Sciences, 1982
- Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.Proceedings of the National Academy of Sciences, 1982
- Statistical analysis of cytogenetic abnormalities in human cancer cellsCancer Genetics and Cytogenetics, 1982
- Translocation (9;11)(p21;q23) in three cases of acute monoblastic leukemiaCancer Genetics and Cytogenetics, 1982
- CYTOGENETIC FEATURES OF HUMAN NEUROBLASTOMAS AND CELL-LINES1981
- ISOLATION, KARYOTYPE, AND CLONAL GROWTH OF HETEROGENEOUS SUB-POPULATIONS OF HUMAN-MALIGNANT GLIOMAS1981